ARROWHEAD PHARMACEUTICALS IN (ARWR) Stock Cash Flow
NASDAQ:ARWR - Nasdaq - US04280A1007 - Common Stock - Currency: USD
| TTM (2024-12-31) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -649.53M | -609.69M | -209.30M | -176.50M | -140.80M | |||
| Depreciation Amortization | 19.57M | 18.59M | 12.50M | 10.40M | 8.30M | |||
| Change In Working Capital | 28.52M | 25.09M | -51.50M | -98.30M | 226.90M | |||
| Interest Paid | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Taxes Paid | 4.73M | 3.74M | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 110.16M | 103.16M | 94.40M | 128.20M | 76.90M | |||
| OPERATING CASH FLOW | -491.28M | -462.85M | -153.90M | -136.10M | 171.20M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -80.33M | -141.47M | -176.70M | -52.80M | -23.60M | |||
| Other Investing Activity | -327.67M | -278.60M | 80.60M | 47.40M | -118.10M | |||
| INVESTING CASH FLOW | -408.00M | -420.07M | -96.20M | -5.40M | -141.70M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 442.00M | 250.00M | N/A | N/A | |||
| Stock Issued/Repurchased | 457.02M | 431.65M | 3.10M | 5.20M | 11.30M | |||
| Other Financing Activity | N/A | -3.13M | 0.00 | 60.00M | N/A | |||
| FINANCING CASH FLOW | 890.89M | 870.52M | 253.10M | 65.20M | 11.30M | |||
| Exchange Rate Effect | 4.07M | 4.20M | -100.00K | -100.00K | N/A | |||
| CHANGE IN CASH | -4.33M | -8.21M | 2.90M | -76.40M | 40.80M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -491.28M | -462.85M | -153.90M | -136.10M | 171.20M | |||
| Capital Expenditure | -80.33M | -141.47M | -176.70M | -52.80M | -23.60M | |||
| FREE CASH FLOW | -571.61M | -604.32M | -330.60M | -188.90M | 147.60M | |||
All data in USD